OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 78 filers reported holding OCULAR THERAPEUTIX INC in Q4 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,492,000 | +50.0% | 536,703 | +23.1% | 0.00% | – |
| Q3 2016 | $2,994,000 | +105.3% | 435,863 | +47.9% | 0.00% | – |
| Q2 2016 | $1,458,000 | -42.4% | 294,608 | +12.5% | 0.00% | – |
| Q1 2016 | $2,530,000 | +1.7% | 261,860 | -1.4% | 0.00% | – |
| Q4 2015 | $2,488,000 | -32.2% | 265,512 | +1.8% | 0.00% | -100.0% |
| Q3 2015 | $3,667,000 | -2.1% | 260,822 | +46.4% | 0.00% | 0.0% |
| Q2 2015 | $3,747,000 | +28.5% | 178,196 | +156.5% | 0.00% | – |
| Q1 2015 | $2,917,000 | +172.6% | 69,475 | +52.7% | 0.00% | – |
| Q4 2014 | $1,070,000 | -11.1% | 45,489 | -43.4% | 0.00% | – |
| Q3 2014 | $1,203,000 | – | 80,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |